4
PRIMARY DOCUMENT
- Filing date
- 26 Jul 2013
- Reporting date
- 24 Jul 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
IOVANCE BIOTHERAPEUTICS, INC. reports
- Company location
- San Carlos, CA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,011 SEC EDGAR filings since 29 Jan 2008
SEC filing history
Showing 851-875 of 984 matching filings.
Per page
25
Current page
35
4
PRIMARY DOCUMENT
- Filing date
- 26 Jul 2013
- Reporting date
- 24 Jul 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4
- Filing date
- 26 Jul 2013
- Reporting date
- 24 Jul 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 25 Jul 2013
- Reporting date
- 24 Jul 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 25 Jun 2013
- Reporting date
- 19 Jun 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
FORM 3
- Filing date
- 11 Jun 2013
- Reporting date
- 24 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
D
File 021-197589
D filing
- Filing date
- 06 Jun 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4
- Filing date
- 04 Jun 2013
- Reporting date
- 22 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G
File 005-85384
NONE
- Filing date
- 03 Jun 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
FORM 3
- Filing date
- 31 May 2013
- Reporting date
- 22 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
File 005-85384
AMENDMENT NO. 1 TO SC 13D/A
- Filing date
- 31 May 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 30 May 2013
- Reporting date
- 22 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
PRIMARY DOCUMENT
- Filing date
- 30 May 2013
- Reporting date
- 22 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 30 May 2013
- Reporting date
- 22 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 29 May 2013
- Reporting date
- 22 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 24 May 2013
- Reporting date
- 20 May 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
NT 10-K
File 000-53127
GENESIS BIOPHARMA NOTIFICATION OF LATE FILING
- Filing date
- 01 Apr 2013
- Reporting date
- 31 Dec 2012
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-53127
GENESIS BIOPHARMA FORM 10-Q
- Filing date
- 25 Jan 2013
- Reporting date
- 30 Sep 2012
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 17 Jan 2013
- Reporting date
- 14 Jan 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
5
OWNERSHIP DOCUMENT
- Filing date
- 09 Jan 2013
- Reporting date
- 31 Dec 2012
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D
File 005-85384
SCHEDULE 13D
- Filing date
- 09 Jan 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 04 Dec 2012
- Reporting date
- 28 Nov 2012
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
NT 10-Q
File 000-53127
NOTIFICATION OF LATE FILING
- Filing date
- 13 Nov 2012
- Reporting date
- 30 Sep 2012
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 18 Oct 2012
- Reporting date
- 12 Sep 2012
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
CURRENT REPORT
- Filing date
- 04 Oct 2012
- Reporting date
- 30 Sep 2012
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing